glp 1 ontario WHO backs GLP-1 meds to treat obesity, but many Islanders can't access them GLP-1 News: Latest Updates on

Prioritize Hydration and Oral Hygiene Carry a refillable water bottle to stay hydrated, especially if you notice your mouth feels dry

Adding a medication that further reduces BMD compounds an existing vulnerability

FDA's April 30, 2026 Proposal On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, finding no clinical need for outsourcing facilities to compound these drugs from bulk drug substances when FDA-approved versions are available

Expected weight loss in a 12-week weight management program is 1-2 lbs

Choose injectable GLP-1s if: Maximum weight loss is your primary goal You want proven, consistent results backed by extensive clinical trials Weekly dosing fits better into your routine than daily medication You have absorption issues or take other morning medications Cost is a concern (compounded injectables are most affordable) You value the gold standard with predictable outcomes Consider FDA-approved oral tablets if: You're extremely needle-averse and won't use injections You have modest weight loss goals You can maintain a strict morning medication routine with 30-minute fasting You prefer FDA-approved medications over compounded options You don't mind the lower bioavailability and the need for higher doses Consider compounded ODT formulations if: You're needle-averse but want to avoid swallowing pills You're willing to try an emerging option without clinical validation You can afford the higher cost compared to compounded injectables You're comfortable with daily dosing For most people seeking significant weight loss, injectable GLP-1 medications currently offer superior results, better convenience (despite being injections), and more cost-effective options through oral options